Skip to main content

Table 1 Demographics and surgery characteristics

From: Determination of the ED95 of intrathecal hyperbaric prilocaine with sufentanil for scheduled cesarean delivery: a dose-finding study based on the continual reassessment method

Dose

35 mg (n = 4)

40 mg (n = 12)

45 mg (n = 20)

50 mg (n = 4)

Age (y)

29 ± 8,76

35,08 ± 5,11

32,85 ± 4,93

29 ± 5,94

Length (cm)

159,5 ± 4,93

164,42 ± 4,45

162,8 ± 6,26

157 ± 6,16

Weight (kg)

73 ± 16,02

82,17 ± 11,93

79,78 ± 11,6

84,68 ± 2,88

Gravity

3 ± 1,41

2,17 ± 1,03

3,1 ± 2,31

2 ± 1,41

Parity

1,25 ± 0,5

0,67 ± 0,49

1,3 ± 1,98

0,75 ± 0,96

Had previous CS (n)

2

5

10

1

Term (w)

38,5 ± 0,58

38,42 ± 1,08

38,40 ± 0,94

38,75 ± 1,26

Time to baby extraction (min)

12,00

8,00 ± 3,49

8,05 ± 2,95

10,25 ± 6,95

Time of surgery (min)

53,00

50,09 ± 14,02

49,32 ± 9,90

56,00 ± 15,64

  1. Data for surgery characteristics (Time to baby extraction and time of surgery) was recorded only if success:
  2. 1 patient for the dose of 35 mg, 11 patients for 40 mg, 19 for 45 mg, 4 for 50 mg